UNMC's world-class research results in breakthroughs that make life better for people throughout Nebraska – and beyond. Our expert faculty are training the next generation of health care providers and improving the care of patients throughout our region.
Specialty
Areas
-
Oncology
-
Pediatrics
-
Heart and Vascular
-
Neurology
Prioritized Clinical Trial Phases
-
Phase I
-
Phase II
-
Phase III
-
Phase IV
Trial Activation
Time
- Average turnaround time for Clinical Trial Agreements, Budget Negotiations, and IRB approval is 18 weeks.
Site Highlights
- UNMC conducts clinical research across more than 35 departments and divisions, supporting nearly 600 active trials at any given time. Our research teams initiate approximately 175 new clinical trials annually, reflecting a strong and sustained commitment to advancing medical knowledge and patient care.
-
The Clinical Research Center serves as the central hub for research activities across the organization. It provides a comprehensive range of services spanning the full lifecycle of a clinical trial. These services are available on an à la carte or bundled basis, allowing for flexibility to meet the unique needs of each study. At any given time, the Clinical Research Center supports approximately 300 active studies.
- The Clinical Research Center houses an established Gene and Cellular Therapy Resource Group which supports research teams initiating trials involving cellular and gene-based therapies. This specialized group oversees 25 active trials on average, providing guidance from initial requests through trial closeout and works collaboratively with the UNMC Biologics Production Facility, ensuring compliance with complex regulatory and operational requirements.
Learn More about UNMC
-
To learn more and connect with the University of Nebraska Medical Center, contact Serena Gaines